US 7,691,909

Application 11/690,576 · Granted Apr 6, 2010

Aerosol gels

Estimated expiration

November 1, 2026

Expired 21 days ago

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
Earliest effective filing
Sep 20, 2005
+ 20 years
Sep 20, 2025
PTA +407d
Nov 1, 2026
No TD
—
Final
Nov 1, 2026

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
March 23, 2007
Earliest effective filing
September 20, 2005
Issue date
April 6, 2010
PTA
+407 days
Base expiry (before PTA)
September 20, 2025

September 20, 2005 + 20 years = September 20, 2025 + 407 PTA days = November 1, 2026

  • Continuation-in-part of application PCTUS2005033832, filed Sep 20, 2005
  • PRO60/613,027 — Provisional — not used for base term
  • PRO60/613,027 — Provisional — not used for base term

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 11/690,576 · US 7,691,909

PatentReply compiles the prosecution history behind US 7,691,909: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US7691909

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.